Analyst Ratings for Boundless Bio Inc. (BOLD) [Buys]
BOLD Rating Summary
BOLD Price Target Summary
- Highest: $25.00 (Leerink Partners)
- Lowest: $20.00 (Piper Sandler)
- Average: $23.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$23.00 (+97.6%)
* Over Last 12-Mos
Rating Score: 2.5 / 10
Percentile Rank: 20%
Avg. $ Target:
$23.00 (+97.6%)
* Over Last 12-Mos
Rating Score: 2.5 / 10
Percentile Rank: 20%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/22/2024 | Guggenheim | Yige Guo | New Coverage | Buy (N/A) |
24.00 (N/A) |
10.47 (11.64) |
11.17% | Details |
| 4/22/2024 | Leerink Partners | Michael Chemy | New Coverage | Outperform (N/A) |
25.00 (N/A) |
10.47 (11.64) |
11.17% | Details |
 |
||||||||
|
||||||||
